These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 1345571)

  • 21. Serum prolactin responses to metoclopramide in Cushing's syndrome and Nelson's syndrome.
    Kasperlik-Zaluska AA; Jeske W
    Acta Endocrinol (Copenh); 1980 Mar; 93(3):351-5. PubMed ID: 6246703
    [No Abstract]   [Full Text] [Related]  

  • 22. Corticotroph tumor progression after adrenalectomy in Cushing's Disease: A reappraisal of Nelson's Syndrome.
    Assié G; Bahurel H; Coste J; Silvera S; Kujas M; Dugué MA; Karray F; Dousset B; Bertherat J; Legmann P; Bertagna X
    J Clin Endocrinol Metab; 2007 Jan; 92(1):172-9. PubMed ID: 17062771
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of somatostatin and bromocryptine on the plasma ACTH level in bilaterally adrenalectomized patients with Cushing's disease.
    Julesz J; Laczi F; Janáky T; László F
    Endokrinologie; 1980 Jul; 76(1):68-72. PubMed ID: 6108208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nelson's syndrome after Cushing's disease in childhood: a continuing problem.
    Thomas CG; Smith AT; Benson M; Griffith J
    Surgery; 1984 Dec; 96(6):1067-77. PubMed ID: 6505960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mechanism of the suppressive action of bromocriptine on adrenocorticotropin secretion in patients with Cushing's disease and Nelson's syndrome.
    Lamberts SW; Klijn JG; de Quijada M; Timmermans HA; Uitterlinden P; de Jong FH; Birkenhäger JC
    J Clin Endocrinol Metab; 1980 Aug; 51(2):307-11. PubMed ID: 6249835
    [No Abstract]   [Full Text] [Related]  

  • 26. Megavoltage pituitary irradiation in the management of Cushing's disease and Nelson's syndrome: long-term follow-up.
    Howlett TA; Plowman PN; Wass JA; Rees LH; Jones AE; Besser GM
    Clin Endocrinol (Oxf); 1989 Sep; 31(3):309-23. PubMed ID: 2559823
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of synthetic corticotropin-releasing factor in normal individuals and in patients with hypothalamic-pituitary-adrenocortical disorders.
    Jørgensen H; Skare S; Frey H; Hanssen KF; Norman N
    Acta Med Scand; 1985; 218(1):79-84. PubMed ID: 2996312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stereotactic radiosurgery before bilateral adrenalectomy is associated with lowered risk of Nelson's syndrome in refractory Cushing's disease patients.
    Bunevicius A; Lavezzo K; Smith PW; Vance ML; Sheehan J
    Acta Neurochir (Wien); 2021 Jul; 163(7):1949-1956. PubMed ID: 33759014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete remission of Nelson's syndrome after 1-year treatment with cabergoline.
    Pivonello R; Faggiano A; Di Salle F; Filippella M; Lombardi G; Colao A
    J Endocrinol Invest; 1999 Dec; 22(11):860-5. PubMed ID: 10710275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gamma Knife surgery for adrenocorticotropic hormone-producing pituitary adenomas after bilateral adrenalectomy.
    Mauermann WJ; Sheehan JP; Chernavvsky DR; Laws ER; Steiner L; Vance ML
    J Neurosurg; 2007 Jun; 106(6):988-93. PubMed ID: 17564169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current status of adrenalectomy for Cushing's disease.
    Brunicardi FC; Rosman PM; Lesser KL; Andersen DK
    Surgery; 1985 Dec; 98(6):1127-34. PubMed ID: 3000013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sustained improvements in plasma ACTH and clinical status in a patient with Nelson's syndrome treated with pasireotide LAR, a multireceptor somatostatin analog.
    Katznelson L
    J Clin Endocrinol Metab; 2013 May; 98(5):1803-7. PubMed ID: 23539733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cushing's disease treated by total adrenalectomy: long-term observations of 43 patients.
    Kelly WF; MacFarlane IA; Longson D; Davies D; Sutcliffe H
    Q J Med; 1983; 52(206):224-31. PubMed ID: 6310673
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nelson's Syndrome.
    Munir A; Newell-Price J
    Arq Bras Endocrinol Metabol; 2007 Nov; 51(8):1392-6. PubMed ID: 18209878
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of preoperative and postoperative ACTH concentrations after bilateral adrenalectomy in Cushing's disease.
    Barnett AH; Livesey JH; Friday K; Donald RA; Espiner EA
    Clin Endocrinol (Oxf); 1983 Mar; 18(3):301-5. PubMed ID: 6305539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nelson's syndrome after bilateral adrenalectomy for Cushing's disease.
    Gil-Cárdenas A; Herrera MF; Díaz-Polanco A; Rios JM; Pantoja JP
    Surgery; 2007 Feb; 141(2):147-51; discussion 151-2. PubMed ID: 17263968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of the long-acting somatostatin analogue SMS 201-995 on ACTH secretion in Nelson's syndrome and Cushing's disease.
    Lamberts SW; Uitterlinden P; Klijn JM
    Acta Endocrinol (Copenh); 1989 Jun; 120(6):760-6. PubMed ID: 2543178
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Nelson's syndrome... revisited.
    Assié G; Bahurel H; Bertherat J; Kujas M; Legmann P; Bertagna X
    Pituitary; 2004; 7(4):209-15. PubMed ID: 16132203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nyctohemeral variation and suppressibility of plasma ACTH in various stages of Cushing's disease.
    Cook DM; Kendall JW; Allen JP; Lagerquist LG
    Clin Endocrinol (Oxf); 1976 Jul; 5(4):303-12. PubMed ID: 183922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies of the basal secretion and the response to TRH (thyrotropin-relapsing factor) of TSH (thyrotropin) and prolactin in Cushing's syndrome and Nelson's syndrome (author's transl)].
    Luton JP; Molinie P; Strauch G; Guilhaume B; Bricaire H
    Sem Hop; 1981 May 8-15; 57(17-18):841-9. PubMed ID: 6262921
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.